Koninklijke Philips (PHG) Change in Accured Expenses (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Change in Accured Expenses came in at $21.1 million in Q1 2026, up 180.14% year-on-year from $7.5 million in Q1 2025, and down 66.47% quarter-over-quarter from $62.9 million in Q4 2025.
Koninklijke Philips (PHG) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Koninklijke Philips' Change in Accured Expenses history runs 18 years deep, the most recent figure standing at $21.1 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 180.14% year-over-year to $21.1 million in Q1 2026; TTM through Mar 2026 was $88.9 million, a 158.61% increase from a year earlier, with the FY2023 full-year figure at -$40.9 million, changed N/A from the prior year.
- Change in Accured Expenses retreated to $21.1 million in Q1 2026 per PHG's latest filing, from $62.9 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $62.9 million in Q4 2025 and bottomed at -$124.8 million in Q2 2022.
- The 5-year median for Change in Accured Expenses is -$26.3 million (2025), against an average of -$27.2 million.
- Across the five-year window, Change in Accured Expenses sank 327.02% in 2022 and surged 215.34% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at -$85.7 million in 2022, then soared by 52.29% to -$40.9 million in 2023, then sank by 33.29% to -$54.5 million in 2024, then soared by 215.34% to $62.9 million in 2025, then plunged by 66.47% to $21.1 million in 2026.
- Per Business Quant, the three latest PHG Change in Accured Expenses figures stand at $21.1 million (Q1 2026), $62.9 million (Q4 2025), and $14.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 74.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.07 Mn |
| Mar 31, 2026 | 21.07 Mn |
| Dec 31, 2025 | 62.86 Mn |
| Dec 31, 2025 | 62.86 Mn |
| Sep 30, 2025 | 14.03 Mn |
| Sep 30, 2025 | 14.03 Mn |
| Jun 30, 2025 | -9.06 Mn |
| Jun 30, 2025 | -9.06 Mn |
| Mar 31, 2025 | -26.30 Mn |
| Mar 31, 2025 | -26.30 Mn |
| Dec 31, 2024 | -54.50 Mn |
| Dec 31, 2024 | -54.50 Mn |
| Sep 30, 2024 | -46.13 Mn |
| Sep 30, 2024 | -46.13 Mn |
| Jun 30, 2024 | -24.77 Mn |
| Jun 30, 2024 | -24.77 Mn |
| Mar 31, 2024 | -11.95 Mn |
| Mar 31, 2024 | -11.95 Mn |
| Dec 31, 2023 | -40.89 Mn |
| Dec 31, 2023 | -40.89 Mn |